Status:
COMPLETED
The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals
Lead Sponsor:
Oregon State University
Conditions:
Modulation of the Human Gut Microbiota by Prebiotic Galactooligosaccharides (GOS)
Eligibility:
All Genders
19-55 years
Phase:
NA
Brief Summary
The purpose of this study was to identify specific microbes that change with supplementation with galactooligosaccharides-prebiotics that are associated with alleviation of lactose intolerance symptom...
Detailed Description
The experimental design of this study was a completely randomized placebo-controlled clinical trial study, which consisted of a one-week screening period followed by a 3-week supplementation period an...
Eligibility Criteria
Inclusion
- \- People with lactose intolerance (formal and informal diagnosis) Fluent in English People who have a primary care provider Have to be 18 years and older
Exclusion
- \- Any known gastrointestinal disease or disorder, or major gastrointestinal surgery Habitual use of laxatives or antacids Diabetes Pregnancy Use of antibiotics within one month prior to the study Use of pre or probiotics within one month prior to the study Any subject who, in the opinion of a physician, has a medical or psychological condition that would preclude them from completing the study Dairy protein allergy (not lactose intolerance) Use of lactose intolerance pills such as "Lactaid" should be avoided during the course of this study
Key Trial Info
Start Date :
October 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 6 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06915129
Start Date
October 25 2021
End Date
December 6 2021
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Milam Hall, Room 001
Corvallis, Oregon, United States, 97331